New hope for advanced cancer: AWT020 trial launches

NCT ID NCT06092580

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times

Summary

This early-stage trial tests a new drug, AWT020, in about 60 adults with advanced solid tumors or lymphoma that has not responded to standard treatments. The main goals are to check the drug's safety at different doses and to see how the body processes it. This study is a first step to find out if AWT020 can help control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alfred Health

    RECRUITING

    Melbourne, Victoria, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • ICON Cancer Center South Brisbane

    RECRUITING

    South Brisbane, Queensland, 4101, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Monash Medical Centre

    RECRUITING

    Clayton, Victoria, 3168, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Southern Oncology Clinical Research Unit (SOCRU)

    RECRUITING

    Bedford Park, South Australia, 5042, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.